The result demonstrated that the risk score was a significant prognostic factor independent of multiple clinicopathological parameters such as the expression level of estrogen receptor (ER), progesterone receptor (PR), human epidermal growth factor receptor (HER-2) as well as the M stage, N stage, T stage, tumor stage. This evidence concerns the gene ERBB2 and neoplasm.